SCHACHLE JOSEPH K — SEC insider filings

SEC reporting owner CIK 1145914. 8 insider filings on record with FilingPulse; latest filed 2026-10-27.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2023-11-27 to 2026-10-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Opus Genetics, Inc. (IRD)Chief Operating Officer81 leg · 2,000 sh · $4,1004 legs · 17,827 sh · $74,6924

Insider filings — SCHACHLE JOSEPH K

FiledFormIssuerReported transactionsSource
2026-10-274Opus Genetics, Inc. (IRD)Sale (S): 4,767 @ $3.56EDGAR
2026-07-274Opus Genetics, Inc. (IRD)Sale (S): 4,644 @ $2.94EDGAR
2026-04-274Opus Genetics, Inc. (IRD)Sale (S): 4,697 @ $5.22EDGAR
2026-03-184Opus Genetics, Inc. (IRD)Sale (S): 3,719 @ $5.25EDGAR
2026-01-264Opus Genetics, Inc. (IRD)Grant/award (A): 250,000 @ $0EDGAR
2025-03-174Opus Genetics, Inc. (IRD)Grant/award (A): 52,500 @ $0 · Grant/award (A): 52,500 (derivative) @ $0EDGAR
2024-03-254Ocuphire Pharma, Inc. (OCUP)Purchase (P): 2,000 @ $2.05EDGAR
2023-11-274Ocuphire Pharma, Inc. (OCUP)Grant/award (A): 300,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-11-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1145914 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs